Immunogenomic landscape analyses of immune molecule signature-based risk panel for patients with triple-negative breast cancer

Triple-negative breast cancer (TNBC) presented as high heterogeneous immunogenicity that lacks useful clinical signatures to risk-stratify immune-benefit subtypes. We hypothesized that molecular-based phenotypic characterization of TNBC tumors and their immunity may overcome these challenges. We enr...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Cun, Li, Ye, Xing, Xiaoming, Zhuang, Jing, Wang, Jigang, Wang, Chunyan, Zhang, Lujun, Liu, Lijuan, Feng, Fubin, Li, Huayao, Gao, Chundi, Yu, Yang, Liu, Jingyang, Sun, Changgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123090/
https://www.ncbi.nlm.nih.gov/pubmed/35614988
http://dx.doi.org/10.1016/j.omtn.2022.04.034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123090/
https://www.ncbi.nlm.nih.gov/pubmed/35614988
http://dx.doi.org/10.1016/j.omtn.2022.04.034

Ejemplares similares